![Xu Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Wei
Direktor/Vorstandsmitglied bei AnHeart Therapeutics (Hangzhou) Co., Ltd.
Aktive Positionen von Xu Wei
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Xu Wei
Statistik
International
China | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |